Fresenius Medical Care AG (FMS)
19.28
+0.31
(+1.63%)
USD |
NYSE |
Apr 18, 13:52
Fresenius Medical Care Cash from Operations (Quarterly): 766.67M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 766.67M |
| September 30, 2023 | 825.31M |
| June 30, 2023 | 1.101B |
| March 31, 2023 | 153.41M |
| December 31, 2022 | 706.43M |
| September 30, 2022 | 609.86M |
| June 30, 2022 | 791.35M |
| March 31, 2022 | 178.08M |
| December 31, 2021 | 799.11M |
| September 30, 2021 | 786.04M |
| June 30, 2021 | 1.110B |
| March 31, 2021 | 250.22M |
| December 31, 2020 | 567.27M |
| September 30, 2020 | 1.070B |
| June 30, 2020 | 2.553B |
| March 31, 2020 | 644.54M |
| December 31, 2019 | 876.42M |
| September 30, 2019 | 954.98M |
| June 30, 2019 | 956.46M |
| March 31, 2019 | 85.83M |
| December 31, 2018 | 848.44M |
| September 30, 2018 | 856.93M |
| June 30, 2018 | 784.40M |
| March 31, 2018 | -55.05M |
| December 31, 2017 | 526.24M |
| Date | Value |
|---|---|
| September 30, 2017 | 798.28M |
| June 30, 2017 | 977.06M |
| March 31, 2017 | 180.67M |
| December 31, 2016 | 843.39M |
| September 30, 2016 | 428.13M |
| June 30, 2016 | 686.72M |
| March 31, 2016 | 179.99M |
| December 31, 2015 | 566.08M |
| September 30, 2015 | 574.15M |
| June 30, 2015 | 354.16M |
| March 31, 2015 | 466.02M |
| December 31, 2014 | 705.26M |
| September 30, 2014 | 765.78M |
| June 30, 2014 | 452.73M |
| March 31, 2014 | 111.86M |
| December 31, 2013 | 536.61M |
| September 30, 2013 | 576.56M |
| June 30, 2013 | 518.70M |
| March 31, 2013 | 325.16M |
| December 31, 2012 | 553.49M |
| September 30, 2012 | 483.48M |
| June 30, 2012 | 472.31M |
| March 31, 2012 | 472.93M |
| December 31, 2011 | 567.82M |
| September 30, 2011 | 504.05M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
153.41M
Minimum
Mar 2023
2.553B
Maximum
Jun 2020
826.29M
Average
791.35M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| DaVita Inc | 485.20M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 0.4825M |
| Biophytis SA | -- |
| TC BioPharm (Holdings) PLC | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -101.71M |
| Cash from Financing (Quarterly) | -800.38M |
| Free Cash Flow | 2.105B |
| Free Cash Flow Per Share (Quarterly) | 0.8493 |
| Free Cash Flow to Equity (Quarterly) | 780.68M |
| Free Cash Flow to Firm (Quarterly) | 566.54M |
| Free Cash Flow Yield | 18.60% |